Case Report: Disappearance of Late Gadolinium Enhancement and Full Functional Recovery in a Young Patient With SARS-CoV-2 Vaccine-Related Myocarditis.
SARS-CoV-2 vaccine
T1/T2 mapping
acute myocarditis
fibrosis
late gadolinium enhancement
oedema
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
01
2022
accepted:
07
02
2022
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
30
3
2022
Statut:
epublish
Résumé
Acute myocarditis was recently demonstrated in previously healthy young male patients after receipt of mRNA SARS-CoV-2 vaccines. Herein, we report on a 21-year-old man who presented with acute fatigue, myalgia, and chest pain 2 days after his second SARS-CoV-2 vaccination with BNT162b2. Cardiac magnetic resonance (CMR) showed acute myocarditis, with mildly impaired LV-function and abundant subepicardial late gadolinium enhancement (LGE). Control CMR after 3 months showed full functional recovery and complete disappearance of LGE. The benefits of SARS-CoV-2 vaccination may significantly exceed the very rare and, in this case, fully reversible adverse effects.
Identifiants
pubmed: 35345490
doi: 10.3389/fcvm.2022.852931
pmc: PMC8957274
doi:
Types de publication
Case Reports
Langues
eng
Pagination
852931Informations de copyright
Copyright © 2022 Korosoglou, Nunninger and Giusca.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206
pubmed: 34185045
Front Cardiovasc Med. 2021 Dec 24;8:737257
pubmed: 35004872
Ann Intern Med. 2022 Mar;175(3):362-370
pubmed: 35073155
JAMA. 2022 Jan 25;327(4):331-340
pubmed: 35076665